• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


| Print

Lantern Pharma (LTRN)

Common Shares
Sell: $2.37|Buy: $2.46|Change: 0.09 (3.86%)

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP

Company profile

Lantern Pharma Inc is a biopharmaceutical company focused on developing oncology drug candidates using its artificial intelligence platform. The company utilizes its proprietary RADR platform to identify, develop, and advance small molecule therapies and antibody-drug conjugates, with a pipeline that includes three lead small molecule drug candidates (LP-300, LP-184, and LP-284) targeting solid tumors and blood cancers. It also advances programs through its subsidiary focused on central nervous system and brain cancers.

Address




Website

https://www.lanternpharma.com

Sector 

Healthcare

Forecast key dates

NameKey Date
Lantern Pharma Inc Fourth Quarter Earnings Conference Call for 20262027-03-30T16:30:00
Lantern Pharma Inc Fourth Quarter Earnings Results for 20262027-03-30T00:00:00
Lantern Pharma Inc Annual Report for 20262027-03-30T00:00:00
Lantern Pharma Inc Third Quarter Earnings Conference Call for 20262026-11-13T09:00:00
Lantern Pharma Inc Third Quarter Earnings Results for 20262026-11-13T00:00:00
Lantern Pharma Inc Annual General Meeting for 20262026-09-18T11:00:00
Lantern Pharma Inc Second Quarter Earnings Results for 20262026-08-13T00:00:00
Lantern Pharma Inc First Quarter Earnings Conference Call for 20262026-05-15T09:00:00
Lantern Pharma Inc First Quarter Earnings Results for 20262026-05-15T00:00:00

Previous key dates

NameKey Date
Lantern Pharma Inc Fourth Quarter Earnings Conference Call for 20252026-03-30T16:30:00
Lantern Pharma Inc Fourth Quarter Earnings Results for 20252026-03-30T00:00:00
Lantern Pharma Inc Annual Report for 20252026-03-30T00:00:00
Lantern Pharma Inc Third Quarter Earnings Conference Call for 20252025-11-13T09:00:00
Lantern Pharma Inc Third Quarter Earnings Result for 20252025-11-13T00:00:00
ThinkEquity Conference 20252025-10-30T11:30:00
Lantern Pharma Inc Annual General Meeting for 20252025-09-19T11:00:00
RedChip Investor Webinar with Lantern Pharma2025-08-26T16:15:00
Lantern Pharma Inc Second Quarter Earnings Results for 20252025-08-13T00:00:00
Lantern Pharma Inc First Quarter Earnings Conference Call for 20252025-05-15T09:00:00
Lantern Pharma Inc First Quarter Earnings Results for 20252025-05-15T00:00:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2026 AJ Bell. All rights reserved.